Quantification of peptides from immunoglobulin constant and variable regions by LC-MRM MS for assessment of multiple myeloma patients-Reference-Cited by-同舟云学术

Quantification of peptides from immunoglobulin constant and variable regions by LC-MRM MS for assessment of multiple myeloma patients

Published:2014-10 Issue:9-10 Volume:8 Page:783-795
ISSN:1862-8346
Container-title:PROTEOMICS - Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Remily-Wood Elizabeth R.¹,Benson Kaaron²,Baz Rachid C.³,Chen Y. Ann⁴,Hussein Mohamad³,Hartley-Brown Monique A.³,Sprung Robert W.¹,Perez Brianna³,Liu Richard Z.⁵,Yoder Sean J.⁶,Teer Jamie K.⁵,Eschrich Steven A.⁵,Koomen John M.¹

Affiliation:

1. Molecular Oncology and Proteomics; Moffitt Cancer Center; Tampa FL USA

2. Pathology; Moffitt Cancer Center; Tampa FL USA

3. Malignant Hematology; Moffitt Cancer Center; Tampa FL USA

4. Biostatistics; Moffitt Cancer Center; Tampa FL USA

5. Cancer Informatics; Moffitt Cancer Center; Tampa FL USA

6. Molecular Genomics; Moffitt Cancer Center; Tampa FL USA

Funder

National Cancer Institute

US Army Medical Research and Materiel Command

National Functional Genomics Center

Bankhead-Coley Cancer Research program of the Florida Department of Health

Publisher

Wiley

Subject

Clinical Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/prca.201300077/fullpdf

Reference48 articles.

1. International staging system for multiple myeloma;Greipp;J. Clin. Oncol.,2005

2. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group;International Myeloma Working Group;Br. J. Haematol.,2003

3. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival;Durie;Cancer,1975

4. International uniform response criteria for multiple myeloma;Durie;Leukemia,2006

5. Proteomic contributions to personalized cancer care;Koomen;Mol. Cell. Proteomics,2008

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An automated workflow based on data independent acquisition for practical and high-throughput personalized assay development and minimal residual disease monitoring in multiple myeloma patients;Clinical Chemistry and Laboratory Medicine (CCLM);2024-06-17

2. Endogenous monoclonal immunoglobulins analyzed using the EXENT® solution and LC-MS;Journal of Mass Spectrometry and Advances in the Clinical Lab;2024-04

3. High-Throughput Glycan Profiling of Human Serum IgG Subclasses Using Parallel Reaction Monitoring Peptide Bond Fragmentation of Glycopeptides and Microflow LC-MS;Journal of Proteome Research;2024-01-17

4. Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM);Clinical Cancer Research;2024-01-03

5. Advances in minimal residual disease monitoring in multiple myeloma;Critical Reviews in Clinical Laboratory Sciences;2023-05-26